Dr Pankaj Modi, CEO, President and Chief Scientific Officer of CTT Pharma is an entrepreneurial clinician and research scientist and has been involved in novel delivery systems for the past few decades. His patented inventions range from spray formulae for the treatment of diabetes which he licensed to Eli Lilly, the topical delivery of botulinum toxins and other molecules that he licensed to Johnson and Johnson, and he is currently in discussions with a major Canadian medical cannabis supplier for a licensing agreement to develop and commercialize CTT Pharma’s novel, smoke-free, drug delivery system in Canada.
Market Data 
Markets 
AI
